共 50 条
- [1] PHASE-II EVALUATION OF WEEKLY CISPLATIN IN METASTATIC HORMONE-RESISTANT PROSTATE-CANCER - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL CANCER TREATMENT REPORTS, 1986, 70 (04): : 541 - 542
- [3] PHASE-II EVALUATION OF MITOGUAZONE IN CANCERS OF THE ESOPHAGUS, STOMACH, AND PANCREAS - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL CANCER TREATMENT REPORTS, 1986, 70 (04): : 533 - 534
- [4] PHASE-II EVALUATION OF PROCARBAZINE IN METASTATIC BREAST-CANCER - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL CANCER TREATMENT REPORTS, 1986, 70 (05): : 679 - 680
- [5] PHASE-II EVALUATION OF FLUDARABINE IN PATIENTS WITH METASTATIC BREAST-CANCER - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL CANCER TREATMENT REPORTS, 1986, 70 (10): : 1235 - 1236
- [6] PHASE-II EVALUATION OF ACLARUBICIN IN LUNG-CANCER - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL CANCER TREATMENT REPORTS, 1986, 70 (06): : 803 - 804
- [7] PHASE-II STUDIES OF ALTERNATIVE HORMONAL AGENTS IN THE TREATMENT OF HORMONE-RESISTANT PROSTATE-CANCER BRITISH JOURNAL OF UROLOGY, 1987, 59 (02): : 182 - 182
- [9] PHASE-II EVALUATION OF ACLARUBICIN IN ADVANCED BREAST-CANCER - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL CANCER TREATMENT REPORTS, 1985, 69 (09): : 1029 - 1030
- [10] MITOGUAZONE IN ADVANCED SQUAMOUS-CELL CARCINOMA OF HEAD AND NECK ORIGIN - A PHASE-II TRIAL OF THE SOUTHEASTERN CANCER STUDY-GROUP CANCER TREATMENT REPORTS, 1986, 70 (04): : 529 - 530